Qualigen Therapeutics
Price & Volume
Stats
See more52W Range | $1.61-$11.50 |
Market Cap | $3.1M |
Shares Short | 52,725 |
Financials
See moreRevenue (12 Mos) | $4.9M |
Revenue Growth (YoY) | 13.7% |
Gross Profit (12 Mos) | $306,537 |
Diluted EPS | -$1.48 |
News
See moreYahoo Finance • 20 days ago
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
Yahoo Finance • 20 days ago
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock
Yahoo Finance • last month
Qualigen Therapeutics secures global patents for cancer drug QN-302
Yahoo Finance • last month
Qualigen Granted New Patents Covering 25 Countries
About
CEO | Mr. Kevin A. Richardson II |
CFO | Mr. Kevin A. Richardson II |
Address | 5857 Owens Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
